The momentum indicators suggest an overbought position, but a reversal is yet to be confirmed.

Bharat Financial Inclusion gets picked up by our Bollinger Band Squeeze scanner, suggesting that a consolidation breakout is expected in the near-term.

Indian pharma major Lupin updated that it has launched Clobazam Oral Suspension 2.5/mg which has already got the USFDA approval in the US market. 

Alembic Pharmaceuticals announced that it received USFDA approval for Moxifloxacin Ophthalmic Solution one of its Abbreviated New Drug Application (ANDA). With this, the total approval count for the company is at 86 approvals. 

Following stocks are close to their 52-week low as at 3.19 p.m. on February 15, 2019.

Kridhan Infra, Mumbai-based steel and steel products manufacturing company, announced that its Singapore based 100 per cent subsidiary, KH Foges Pte won new order worth Rs. 187cr (S$ 36 million) and the certification to bid for unlimited value projects for pilling.

The markets on February 15, 2019 opened Flat. BSE Sensex is trading at 35,816.29, down by 59.93 points and the Nifty is trading at 10,728.10, down by 17.95 points.

Investing systematically with the help of SIP is not a new phenomenon for investors, but it is important to understand how to look at SIPs during volatile times. Should you stop or continue your SIP, let’s find out.

Overall volumes in futures & options currently stand at 2,71,09,084 contracts with a turnover of Rs. 15,89,159.28 crore.

Overall volumes in futures & options currently stand at 2,71,09,084 contracts with a turnover of Rs. 15,89,159.28 crore.